Skip to main content

Table 2 Cumulative proportion surviving of the 4 groups

From: Survival after chemotherapy and/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study

Months

Chemo-radiotherapy

Chemotherapy

Radiation

Stent

6

60.60%

43.47%

58.33%

38.46%

12

39.39%

34.78%

25.00%

19.23%

18

30.30%

13.04%

08.33%

07.69%

24

24.24%

08.69%

0%

03.84%

30

10.60%

04.34%

 

01.92%

36

07.57%

02.17%

 

00.96%

42

06.06%

0%

 

0%

48

05.19%

   

54

04.32%

   

60

03.46%